amyotrophic lateral sclerosis

AAN 2024: In ALS trial, PrimeC lowered nerve damage biomarker

ALS News Today - 19 Apr 2024
AAN 2024: In ALS trial, PrimeC lowered nerve damage biomarker  ...

• More

Researchers set new standards for nanoparticles, helping patients with MS, ALS, Parkinson's disease

Phys.org - 19 Apr 2024
Researchers set new standards for nanoparticles, helping patients with MS, ALS, Parkinson's disease  ...

• More

Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?

BioSpace - 17 Apr 2024
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?  ...

• More

Novel Treatment Appears to Show Benefit in ALS

Medpage Today - 18 Apr 2024
Novel Treatment Appears to Show Benefit in ALS  ...

• More

This Common Household Habit Could Be Increasing Your Risk of ALS

SciTechDaily - 16 Apr 2024
This Common Household Habit Could Be Increasing Your Risk of ALS  ...

• More

Battle against fatal neurodegenerative disease advances on two fronts

Medical Xpress - 19 Apr 2024
Battle against fatal neurodegenerative disease advances on two fronts  ...

• More

AAN 2024: ALS trial investigator shares details of Relyvrio failure

ALS News Today - 17 Apr 2024
AAN 2024: ALS trial investigator shares details of Relyvrio failure  ...

• More

AAN 2024: Stem cell therapy for ALS may slow disease for some

ALS News Today - 18 Apr 2024
AAN 2024: Stem cell therapy for ALS may slow disease for some  ...

• More

Study: Chemicals found in home garages associated with increased...

ALS News Today - 17 Apr 2024
Study: Chemicals found in home garages associated with increased...  ...

• More

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

The New York Times - 04 Apr 2024
A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says  ...

• More

Amyotrophic lateral sclerosis (ALS): What causes it and risk factors

Medical News Today - 19 Apr 2024
Amyotrophic lateral sclerosis (ALS): What causes it and risk factors  ...

• More

An aberrant fused in sarcoma liquid droplet of amyotrophic lateral sclerosis pathological variant, R495X, accelerates ...

Nature.com - 17 Apr 2024
An aberrant fused in sarcoma liquid droplet of amyotrophic lateral sclerosis pathological variant, R495X, accelerates ...  ...

• More

MSU researchers set new standards and show how a new treatment helps patients with MS, ALS, Parkinson's disease

MSUToday - 19 Apr 2024
MSU researchers set new standards and show how a new treatment helps patients with MS, ALS, Parkinson's disease  ...

• More

Chemicals Stored in Your Garage Could Raise Odds for ALS

U.S. News & World Report - 15 Apr 2024
Chemicals Stored in Your Garage Could Raise Odds for ALS  ...

• More

Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS

BioSpace - 17 Apr 2024
Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS  ...

• More

TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome ...

BMC Medicine - 05 Mar 2024
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome ...  ...

• More

Shifting the paradigm – novel approaches to amyotrophic lateral sclerosis therapy

Pharmaceutical Technology - 29 Feb 2024
Shifting the paradigm – novel approaches to amyotrophic lateral sclerosis therapy  ...

• More

Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis

ScienceDirect.com - 02 Mar 2024
Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis  ...

• More

Paints and Pesticides Linked to ALS Risk

Neuroscience News - 11 Apr 2024
Paints and Pesticides Linked to ALS Risk  ...

• More